InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: BIOChecker4 post# 230703

Thursday, 01/16/2020 3:05:17 PM

Thursday, January 16, 2020 3:05:17 PM

Post# of 462244
“ Biogen looked at A2-73 carefully and walked away.”

Completely agree. We have seen time and again, BP make BO or collaboration offers very quickly if they see potential. (Even investors also do the same - depending on what their DD says and conviction they have, they decide to invest or sell the stock)

The fact that after exploring-investigating A2-73 for MS, they did not move forward - it tells you that they did not find the necessary potential. M was not required to inform SH about failure or any negative response from BIIB as it was not clinical trial and more of exploration.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News